Pharmaceuticals


0 Results Found

Sorry we couldn't find any results for this search, try one of the popular keyword searches below;



News for category "Pharmaceuticals"

Innocrin Pharmaceuticals, Inc. Raises $28 Million in Series D Financing

Innocrin Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing small-molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers, today announced the completion of a $28 million Series D financing round.

 

Momenta Pharmaceuticals (MNTA) Enters Overbought Territory - Tale of the Tape

Momenta Pharmaceuticals (MNTA) Enters Overbought Territory